Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Genomenon, Inc. — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plans Book a 15-min walkthrough

▶

Watch the 2-minute tour · with sound

Genomenon Partners with Genomize to Integrate Mastermind and CKB into Platform

Mar 27, 2025•about 1 year ago

Contract Type

partnership

Ann ArborBiotechnologyHardwareresearch

Description

Genomize and Genomenon have announced a strategic partnership to integrate both Mastermind and CKB into the Genomize platform. This collaboration aims to provide more comprehensive and accurate genomic insights, ultimately improving patient outcomes and advancing precision medicine. The partnership will expand access to curated genomic data and facilitate more informed decision-making in research and clinical settings.

Company Information

Company

Genomenon, Inc.

Location

3135 S. STATE STREET

Ann Arbor, Michigan, United States

About

Genomenon is a genomics intelligence company dedicated to improving the quality of life of genetic disease and cancer patients by making genomic information actionable. Blending the power of AI with the precision of genomic expertise, the company empowers pharmaceutical companies and the clinical diagnostic community with empirical genomic evidence and insights that both support the development of novel therapeutics and speed diagnostic assessments and treatment recommendations.

Predictive Intelligence

Strategic

ML-powered predictions for Genomenon, Inc.'s next move

Learn about Strategic plan

Related People

Suggested for you

Agreement Insights

Based on industry data

Strategic partnership established

Partnership agreements typically involve technology integration and joint go-to-market strategies

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months